How are you incorporating abscopal radiation into your practice for metastatic NSCLC?   

What is the best evidence for what dose to use? When would you give it in relation to the checkpoint inhibitors? Which metastatic sites do you choose to radiate?



Answer from: Radiation Oncologist at Academic Institution